| 000 | 01485 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515055116.0 | ||
| 264 | 0 | _c20070904 | |
| 008 | 200709s 0 0 eng d | ||
| 022 | _a1549-1676 | ||
| 024 | 7 |
_a10.1371/journal.pmed.0040021 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDromer, Françoise | |
| 245 | 0 | 0 |
_aDeterminants of disease presentation and outcome during cryptococcosis: the CryptoA/D study. _h[electronic resource] |
| 260 |
_bPLoS medicine _cFeb 2007 |
||
| 300 |
_ae21 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _xdrug therapy |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAmphotericin B _xtherapeutic use |
| 650 | 0 | 4 |
_aAntifungal Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCryptococcosis _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aCryptococcus neoformans _xclassification |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFlucytosine _xtherapeutic use |
| 650 | 0 | 4 |
_aFrance _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMeningoencephalitis _xdrug therapy |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMathoulin-Pélissier, Simone | |
| 700 | 1 | _aLaunay, Odile | |
| 700 | 1 | _aLortholary, Olivier | |
| 773 | 0 |
_tPLoS medicine _gvol. 4 _gno. 2 _gp. e21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pmed.0040021 _zAvailable from publisher's website |
| 999 |
_c16844590 _d16844590 |
||